ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 168 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,032,511 | -28.9% | 876,633 | -0.1% | 1.28% | -25.0% |
| Q2 2023 | $5,668,216 | -13.8% | 877,433 | +0.6% | 1.70% | -18.1% |
| Q1 2023 | $6,578,520 | -25.2% | 872,483 | +0.4% | 2.08% | -32.2% |
| Q4 2022 | $8,798,743 | -18.5% | 868,583 | -20.4% | 3.06% | -20.2% |
| Q3 2022 | $10,795,000 | -7.0% | 1,091,505 | -0.8% | 3.84% | -3.8% |
| Q2 2022 | $11,612,000 | +7.1% | 1,099,755 | -1.1% | 3.99% | +23.3% |
| Q1 2022 | $10,842,000 | -36.4% | 1,111,979 | -6.7% | 3.24% | -25.5% |
| Q4 2021 | $17,051,000 | -30.5% | 1,192,379 | -2.5% | 4.35% | -26.8% |
| Q3 2021 | $24,518,000 | -7.7% | 1,223,429 | +1.4% | 5.93% | -0.9% |
| Q2 2021 | $26,554,000 | – | 1,206,979 | – | 5.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DCVC Bio GP, LLC | 7,305,761 | $104,472,000 | 100.00% |
| Founders Fund VII Management, LLC | 3,773,530 | $53,961,000 | 89.75% |
| Gruss & Co., LLC | 426,966 | $6,106,000 | 16.39% |
| SB Management Ltd | 9,817,190 | $140,386,000 | 13.88% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $58,703,000 | 5.51% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $45,346,000 | 4.36% |
| Intellectus Partners, LLC | 1,192,379 | $17,051,000 | 4.35% |
| Founders Fund Growth Management, LLC | 407,017 | $5,820,000 | 3.28% |
| ArchPoint Investors | 461,289 | $6,596,000 | 1.96% |
| Belmont Capital, LLC | 150,000 | $2,145,000 | 1.68% |